• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.27% Nasdaq Down 0.19%

    Cellectar Biosciences, Inc. (CLRB)

    -NasdaqCM
    3.28 Up 0.09(2.82%) 2:22PM EDT
    Add to Portfolio
    Prev Close:3.19
    Open:3.18
    Bid:2.16 x 200
    Ask:3.49 x 500
    1y Target Est:2.50
    Beta:0.42
    Earnings Date:Aug 18 - Aug 24 (Est.)
    Day's Range:3.11 - 3.28
    52wk Range:1.76 - 6.00
    Volume:460
    Avg Vol (3m):13,633
    Market Cap:24.81M
    P/E (ttm):N/A
    EPS (ttm):-1.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLRB

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-13) :N/A
    Quarterly EPS Est (Mar-13) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cellectar Biosciences, Inc., a biopharmaceutical company, develops compounds for the treatment, diagnosis, and imaging of cancer. The company’s proprietary product candidates include I-124-CLR1404, a small-molecule, broad-spectrum, and cancer... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback